Assessing and Treating Pediatric Patients With Mood Disorders Essay
Assessing and Treating Pediatric Patients With Mood Disorders Essay
I WILL LIKE THE WRITER 1747 TO EXECUTE THIS ORDER PLEASE. PLS FOLLOW THE RUBRICS. PLS COPY AND PASTE THE LINK BELOW TO YOUR BROWSER TO ASSESS THE CASE STUDY. https://cdnfiles.laureate.net/2dett4d/Walden/NURS/6521/05/mm/decision_trees/week_02/index.html The Assignment: 5 pages Examine Case Study: An African American Child Suffering From Depression. You will be asked to make three decisions concerning the medication to prescribe to this patient. Be sure to consider factors that might impact the patient’s pharmacokinetic and pharmacodynamic processes. At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Assessing and Treating Pediatric Patients With Mood Disorders Essay. Before you make your decision, make sure that you have researched each option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature. RUBRICS 1) Introduction to the case (1 page) Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient. 2) Decision #1 (1–2 pages) • Which decision did you select? • Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature. • Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature. • What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature). • Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples. 3) Decision #2 (1–2 pages) • Which decision did you select? • Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature. • Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature. Assessing and Treating Pediatric Patients With Mood Disorders Essay. • What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature). • Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples. 4) Decision #3 (1–2 pages) • Which decision did you select? • Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature. • Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature. • What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature). • Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples. 5) Conclusion (1 page) • Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature. Learning Resources Required Readings (click to expand/reduce) American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596 Howland, R. H. (2008a). Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 1: Study design. Journal of Psychosocial Nursing and Mental Health Services, 46(9), 21–24. https://doi.org/10.3928/02793695-20080901-06 Howland, R. H. (2008b). Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 2: Study outcomes. Journal of Psychosocial Nursing and Mental Health Services, 46(10), 21–24. https://doi.org/10.3928/02793695-20081001-05 Lorberg, B., Davico, C., Martsenkovskyi, D., & Vitiello, B. (2019). Principles in using psychotropic medication in children and adolescents. In J. M. Rey & A. Martin (Eds.), IACAPAP e-textbook of child and adolescent mental health. https://iacapap.org/content/uploads/A.7-Psychopharmacology-2019.1.pdf Magellan Health. (2013).Assessing and Treating Pediatric Patients With Mood Disorders Essay. Appropriate use of psychotropic drugs in children and adolescents: A clinical monograph. http://www.magellanhealth.com/media/445492/magellan-psychotropicdrugs-0203141.pdf Poznanski, E. O., & Mokros, H. B. (1996). Child depression rating scale—Revised. Western Psychological Services. Rao, U. (2013). Biomarkers in pediatric depression. Depression & Anxiety, 30(9), 787–791. https://doi.org/10.1002/da.22171 Yasuda, S. U., Zhang, L. & Huang, S.-M. (2008). The role of ethnicity in variability in response to drugs: Focus on clinical pharmacology studies. Clinical Pharmacology & Therapeutics, 84(3), 417–423. https://web.archive.org/web/20170809004704/https://www.fda.gov/downloads/Drugs/ScienceResearch/…/UCM085502.pdf
Psychopharmacologic Management (Off-Label) of an 8 Year-Old African American Male Child Presenting with Depression and Suicidal Ideation
Major depressive disorder (MDD) belongs to a diagnostic category known as ‘Depressive Disorders’ in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The other conditions in this diagnostic category include mood dysregulation disorder and dysthymia (persistent depressive disorder) among others. The main common characteristics for all these depressive conditions are a feeling of sadness, an irritable mood, and emptiness (APA, 2013). The case study presents an 8 year-old male African American child who is diagnosed with significant depression (major depressive disorder) using the Children’s Depression Rating Scale (CDRS). Assessing and Treating Pediatric Patients With Mood Disorders Essay. According to the history and mental status examination (MSE), the 8 year-old boy also meets the DSM-5 diagnostic criteria for MDD. He has complained of feeling sad (anhedonia), he isolates himself from the other children in school, is irritated occasionally, and shows a blunted affect on MSE. Among the criteria for this diagnosis in the DSM-5 are a markedly reduced interest/ pleasure in daily activities, sustained sadness or emptiness as shown in the mood, feelings of worthlessness, psychomotor retardation or agitation, inability to concentrate, and thoughts about death (APA, 2013). The 8 year-old boy meets all these criteria, meaning that the diagnosis is correct. It is reported that his growth and development has so far been normal and the physical examination and laboratory tests done on him have revealed nothing significantly wrong physically. This paper is about the decision to be made on the psychopharmacological management of this 8 year-old boy’s depression.
Decision Point 1: Choice of Appropriate Medication
The decision taken in making the choice of medication for this 8 year-old African American boy with MDD was to give him off-label sertraline (Zoloft) at an initial dose of 25 mg orally every day (Rosenthal & Burchum, 2018; Stahl, 2017). Sertraline is a selective serotonin reuptake inhibitor (SSRI) antidepressant that is only FDA-approved for treating major depressive disorder in adults. In children, it is only approved by the FDA for treating obsessive-compulsive disorder (Stahl, 2017). The choice to use it here to treat depression in a child falls under off-label prescription of antidepressants to children (Vijay et al., 2018; Allen et al., 2018; Mir & Geer, 2017). Off-label drugs are medications that are FDA-approved for use in adults to treat a condition that presents in a child. Because of lack of alternatives, the clinician decides to use the medication in the child and tailor its dosage to their weight and profile. Assessing and Treating Pediatric Patients With Mood Disorders Essay. It is referred to as off-label use because there is no safety profile information on the use of sertraline (Zoloft) in children to treat depression. This kind of use is not indicated in the package insert and is also not covered in the drug’s license (it is off-label). However, this is a common practice.
Some of the reasons for off-label prescription of psychopharmacologic agents are:
- Lack of FDA-approved medications for a particular condition in children when a similar condition has an FDA-approved medication in adults.
- When the child’s life is at risk such as from suicidal ideation/ suicidality.
